关于阿曼塔丁的分子对接,衍生,表征和生物测试
Zarmeena Yasmeen1, Mohsin Abbas Khan1, Irshad Ahmad1
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, 63100, Pakistan.
Future medicinal chemistry
|August 9, 2024
概括
新的船只新船
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 抗病毒剂 抗病毒剂
背景情况:
- 衍生在药物发现中至关重要,因为它可以增强药物特性.
- 为了提高安全性和有效性,正在探索阿曼塔丁衍生物.
- 希夫的基地为新型治疗剂提供了多功能支架.
研究的目的:
- 合成和评估来自阿曼塔丁的新型希夫基.
- 评估新化合物的抗病毒和抗糖尿病潜力.
- 为了确定药物设计的化合物.
主要方法:
- 通过凝结反应合成希夫基 (AD1-AD11).
- 使用光谱 (FTIR,NMR) 和色谱技术 (TLC,LC-MS) 进行表征.
- 在研究中,分子对接,以及体外抗病毒 (血凝素测试) 和酶抑制试验 (α-氨酶,α-葡萄糖酶).
主要成果:
- 与阿曼塔丁相比,AD2,AD3和AD9-AD11化合物显示出增强的抗病毒活性.
- AD2和AD3显示出对α-氨酸酶的显著抑制.
- AD7和AD10表现出对α-葡萄糖酶的强烈抑制.
结论:
- 合成的希夫基具有有前途的抗病毒和抗糖尿病特性.
- 特定的衍生物 (AD2,AD3,AD7,AD10,AD9-AD11) 可以作为化合物.
- 这项研究强调了基于阿曼塔丁的希夫基在开发新型抗病毒药物和抗糖尿病药物的潜力.
相关概念视频
Structure-Activity Relationships and Drug Design
687
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
687
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K


